|
AIMP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.116300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.580700E-03 |
| Normal-vs-Stage2 |
3.231200E-01 |
| Normal-vs-Stage3 |
1.683950E-03 |
| Normal-vs-Stage4 |
2.275200E-01 |
| Stage1-vs-Stage2 |
6.024400E-01 |
| Stage1-vs-Stage3 |
2.656200E-01 |
| Stage1-vs-Stage4 |
7.135400E-01 |
| Stage2-vs-Stage3 |
1.890570E-01 |
| Stage2-vs-Stage4 |
9.759200E-01 |
| Stage3-vs-Stage4 |
2.020000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.021900E-02 |
| Normal-vs-AfricanAmerican |
9.739100E-03 |
| Normal-vs-Asian |
5.178500E-02 |
| Caucasian-vs-AfricanAmerican |
4.833400E-01 |
| Caucasian-vs-Asian |
5.366000E-01 |
| AfricanAmerican-vs-Asian |
6.666600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.620800E-03 |
| Normal-vs-Female |
6.212000E-02 |
| Male-vs-Female |
4.215600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.178200E-03 |
| Normal-vs-Extreme_Weight |
2.171900E-02 |
| Normal-vs-Obese |
3.459800E-02 |
| Normal-vs-Extreme_Obese |
2.570600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.580800E-01 |
| Normal_Weight-vs-Obese |
4.086400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.004600E-01 |
| Extreme_Weight-vs-Obese |
9.646600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.083000E-01 |
| Obese-vs-Extreme_Obese |
7.991600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.674200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.771900E-02 |
| Normal-vs-Age(61-80Yrs) |
7.981200E-03 |
| Normal-vs-Age(81-100Yrs) |
6.577400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.028000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.980800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.129570E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.641800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.305170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.547400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.767800E-02 |
| Normal-VS-Type2 PRCC |
3.010400E-04 |
| Normal-VS-KIRP CIMP |
5.114400E-01 |
| Normal-VS-Unclassified PRCC |
4.204000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.658600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.730000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.834600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.774400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.143600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.278600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.399440E-04 |
| Normal-vs-N1 |
7.629800E-01 |
| Normal-vs-N2 |
5.019800E-02 |
| N0-vs-N1 |
8.479800E-02 |
| N0-vs-N2 |
8.892000E-01 |
| N1-vs-N2 |
4.155000E-01 |
|
|
